Luteolin target HSPB1 regulates endothelial cell ferroptosis to protect against radiation vascular injury
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0311922 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Li Wen und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Jilin University, Changchun, P. R. China. Hauptthemen laut MEDLINE: Luteolin, Ferroptosis, Human Umbilical Vein Endothelial Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Vascular endothelial damage due to ionizing radiation is the main pathological process of radiation injury and the main cause of damage to various organs in nuclear accidents. Ferroptosis plays an important role in ionizing radiation-induced cell death. We have previously reported that luteolin is highly resistant to ferroptosis. In the present study, body weight, microvessel count, H&E, and Masson staining results showed that luteolin rescued radial vascular injury in vivo . Cell Counting Kit 8 (CCK8), Giemsa staining clarified the anti-ferroptosis ability of luteolin with low toxicity. Malondialdehyde (MDA), superoxide dismutase (SOD), NADP + /NADPH, Fe 2+ staining, dihydroethidium (DHE) and MitoTracker assays for ferroptosis-related metrics, we found that luteolin enhances human umbilical vein endothelial cells (HUVECs) antioxidant damage capacity. Drug affinity responsive target stability (DARTS), surface plasmon resonance (SPR), computer simulated docking and western blot showed that heat shock protein beta-1 (HSPB1) is one of the targets of luteolin action. Luteolin inhibits ferroptosis by promoting the protein expression of HSPB1/solute carrier family 7 member 11 (SLC7A11)/ glutathione peroxidase 4 (GPX4). In conclusion, we have preliminarily elucidated the antioxidant damage ferroptosis ability and the target of action of luteolin to provide a theoretical basis for the application of luteolin in radiation injury diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Nursing, Jilin University, Changchun, P. R. China.
- Department of Special Medicine, School of Basic Medicine, Qingdao University, Qingdao, P. R. China.
- Laboratory of Molecular Diagnosis and Regenerative Medicine, The Affiliated Hospital of Qingdao University, Qingdao, P. R. China.
- Department of Cardiovascular, The Sixth Medical Center of Chinese PLA General Hospital, Haidian District, Beijing, China.
- Beijing Institute of Radiation Medicine, Beijing, P. R. China.
ORCID-Profile: Fengjun Xiao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wen, L., Zhang, W., Hu, J., Chen, T., Wang, Y., Lv, C., Li, M., Wang, L., & Xiao, F. (2024). Luteolin target HSPB1 regulates endothelial cell ferroptosis to protect against radiation vascular injury. PLOS ONE. https://doi.org/10.1371/journal.pone.0311922
Vancouver
Wen L, Zhang W, Hu J, Chen T, Wang Y, Lv C, et al. Luteolin target HSPB1 regulates endothelial cell ferroptosis to protect against radiation vascular injury. PLOS ONE. 2024. doi:10.1371/journal.pone.0311922
BibTeX
@article{Wen2024,
author = {Wen, Li and Zhang, Weiyuan and Hu, Jia and Chen, Tao and Wang, Yiming and Lv, Changchang and Li, Min and Wang, Lisheng and Xiao, Fengjun},
title = {Luteolin target HSPB1 regulates endothelial cell ferroptosis to protect against radiation vascular injury},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0311922}
}
EUVIMED